2024 Fall Conference | C24 - Neurology Update 7: Neuromuscular Disease; Epilepsy

Date Sunday 10/27/24

Time 07:30 AM - 09:00 AM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Vijay K. Ramanan, MD, PhD, Casey S. Albin, MD

Topic(s) Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Neuromuscular Disease: After this session participants should be familiar with recent advances in myasthenia, ALS, and Duchenne muscular dystrophy.

CME Available 1.50 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Teaching Styles Didactic

Program Materials

Event Timeline
07:30 AM - 08:15 AM PDT	Speaker	Neuromuscular Disease Chamindra G. Laverty, MD
08:15 AM - 09:00 AM PDT	Speaker	Epilepsy Shawniqua Williams Roberson, MD

Faculty Disclosures
Vijay K. Ramanan, MD, PhD	The institution of Dr. Ramanan has received research support from the National Institutes of Health. The institution of Dr. Ramanan has received research support from the Mangurian Foundation for Lewy Body Disease Research. The institution of Dr. Ramanan has received research support from as part of clinical trials sponsored by the Alzheimer's Association, Eisai, the Alzheimer's Treatment and Research Institute at USC, and Transposon Therapeutics, Inc.. The institution of Dr. Ramanan has received research support from Medscape. Dr. Ramanan has received personal compensation in the range of $500-$4,999 for serving as a Conference Speaker/Organizer (Honoraria) with AANI.
Casey S. Albin, MD	Dr. Albin has received personal compensation in the range of $0-$499 for serving as a Consultant for Azurity Pharmaceutical. Dr. Albin has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum: Life Long Learning in Neurology. Dr. Albin has received research support from American Academy of Neurology. Dr. Albin has received publishing royalties from a publication relating to health care. Dr. Albin has received personal compensation in the range of $500-$4,999 for serving as a Instructor with Resuscitation Leadership Academy.
Shawniqua Williams Roberson, MD	Dr. Williams Roberson has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. The institution of Dr. Williams Roberson has received research support from the National Institute on Aging. The institution of Dr. Williams Roberson has received research support from Brain & Behavior Research Foundation. Dr. Williams Roberson has received personal compensation in the range of $0-$499 for serving as a Reviewer with the National Institutes of Health. Dr. Williams Roberson has received personal compensation in the range of $0-$499 for serving as a Visiting Speaker with University of Pennsylvania. Dr. Williams Roberson has received personal compensation in the range of $0-$499 for serving as a Faculty Speaker with the International Symposium for Intensive Care and Emergency Medicine.
Chamindra G. Laverty, MD	The institution of Dr. Laverty has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta . Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Biosciences. Dr. Laverty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. The institution of Dr. Laverty has received research support from Sarepta. The institution of Dr. Laverty has received research support from Novartis Gene Therapies. The institution of Dr. Laverty has received research support from Italfarmaco. The institution of Dr. Laverty has received research support from Fibrogen. The institution of Dr. Laverty has received research support from Avidity. The institution of Dr. Laverty has received research support from Dyne.